Proactive Investors - Run By Investors For Investors

Auscann targeting pain management with Australian cannabinoid products

Elaine Darby, managing director of Auscann Group Holdings Ltd (ASX:AC8), spoke to Proactive Investors at the ASX Small and Mid-Cap Conference in Sydney.

Auscann is continuing to make steady progress towards releasing its first medicinal cannabis products during the financial year 2019. The company has established several strategic partnerships in Australia, Chile and Canada and is advancing its position as a fully-integrated cannabinoid pharmaceutical company.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full AC8 profile View Profile

AusCann Group Holdings Ltd Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use